Ascension Health in Texas uses AI that can read CT scans for stroke and pulmonary embolism to activate care teams before the images even get into the PACS.
Cardiovascular Associates of America, backed by Webster Equity Partners, currently includes practices in eight different states. Its partner cardiologists now have preferred access to multiple cloud-based services provided by Athenahealth.
Silk Road Medical is known for developing transcarotid artery revascularization (TCAR), a new-look procedure designed to reduce the risk of stroke in patients with carotid artery disease.
Peter Monteleone, MD, national director of cardiovascular research at Ascension Health, explains the growing role of interventional cardiology in pulmonary embolism treatment and PERT teams.
The American Society of Nuclear Cardiology (ASNC) team at the 2024 AMA meeting, Georgia Lawrence, JD, ASNC director of regulatory affairs; Suman Tandon, MD, FASNC, delegate to the AMA HOD and cardiac imager at NYU Langone; and Kathy Flood, ASNC CEO.
The American Society of Nuclear Cardiology (ASNC) supports an AMA policy that condemns the use AI to make prior authorization decisions rather than a doctor or clinician.
MCOT image taken during HRS 2023. Photo by Dave Fornell.
Long-term continuous monitoring (LTCM) wearable devices now make up 40% or more of the remote ECG monitoring market due to ease of use and collection of more data.
Cardiac ultrasound exams often require the sonographer to reach over a patient and hold the probe firmly against the chest while their body faces a different direction to operate the ultrasound machine, which can lead to orthopedic issues over time. Photo at ASE 2023 by Dave Fornell
Orthopedic issues are the biggest work-related injury in cardiology, but this low cost intervention may help.
The WISEWOMAN program proved to be a useful intervention to screen low-income, uninsured women and offer them risk reduction counseling to improve blood pressure, diet and physical activity.
Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.